About this case
Elmiron (pentosan polysulfate sodium) is prescribed for interstitial cystitis and bladder pain. In June 2020 the label was updated to warn of retinal pigmentary changes. Lawsuits claim the manufacturer, Janssen, failed to warn patients sooner about the risk of permanent eye damage.
Where the case stands
Most Elmiron cases have been resolved through confidential settlements and the federal litigation is winding down. Some attorneys still review claims with a documented diagnosis such as pigmentary maculopathy.
Status last reviewed November 2026. Lawsuit developments change often.
Who may qualify
- You took Elmiron, typically for a year or longer
- You were diagnosed with an eye condition such as pigmentary maculopathy or retinal damage
- Your claim is within your state's filing deadline
Injuries and conditions involved
Free · Confidential · About 2 minutes
Find out if you qualify
Answer a few quick questions about your Elmiron claim. There's no cost and no obligation.
See If I QualifyPrefer to talk? Call (877) 342-6154


